---

---

publishing date : 2021 - 09 - 20    tags : Positive   

save search

---

CUMULUS MEDIA ADDS SENIOR POSITIONS FOR MULTI-PLATFORM CONTENT DEVELOPMENT
Published: 2021-09-20 (Crawled : 16:00) - cumulusmedia.com
CMLS | $2.77 2.59% 41K |

Consumer Services

| -72.51% | O: 0.31% H: 2.44% C: 0.41%
media positive platform

---

Continuous Positive Airway Pressure (CPAP) Devices Market analysis in Health Care Equipment Industry | $ 1.08 Bn Growth Expected During 2021-2025 | 17,000+ Technavio Research Reports
Published: 2021-09-20 (Crawled : 14:15) - prnewswire.com
RMD | $183.74 1.88% 510K |

Health Technology

| -36.93% | O: -1.35% H: 1.66% C: 0.76%
positive growth device research

---

Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Published: 2021-09-20 (Crawled : 14:00) - globenewswire.com
MMSI | $74.705 1.99% 120K |

Health Technology

| 2.23% | O: -1.65% H: 1.76% C: 1.56%
positive results positive results

---

Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
VERU | $1.33 4.72% 1.9M |

Health Technology

| -85.79% | O: -4.25% H: 3.62% C: -1.17%
GILD | $67.37 0.63% 2.4M |

Health Technology

| -5.48% | O: 0.14% H: 1.4% C: 0.04%
prostate cancer phase 1 positive cancer phase 1b sabizabulin phase 2b

---

Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GLPG | News | $29.67 2.06% 88K |

Health Technology

| -47.71% | O: -2.97% H: 2.56% C: 1.65%
fibrosis positive drug preclinical cudetaxestat pre-clinical

---

Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
EDSA | $4.38 1.7K |

Health Technology

| -21.86% | O: 68.6% H: 26.98% C: 26.14%
covid phase 2 positive antibody biotech iot covid-19

---

Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published: 2021-09-20 (Crawled : 12:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0 |

Health Technology

| -65.56% | O: 0.78% H: 11.36% C: 3.1%
phase 2 lung cancer positive results cancer topline

---

BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
BYSI | $2.26 7.11% 92K |

Health Technology

| -90.67% | O: -19.1% H: 7.65% C: -16.07%
positive phase 3 plinabulin

---

BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical Oncology (ESMO) 2021 Congress
Published: 2021-09-20 (Crawled : 12:00) - globenewswire.com
BYSI | $2.26 7.11% 92K |

Health Technology

| -90.67% | O: -19.1% H: 7.65% C: -16.07%
lung cancer europe positive cancer phase 3 plinabulin

---

Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
SYBX | $1.84 51K |

Health Technology

| -41.77% | O: 11.39% H: 14.77% C: 5.4%
phase 2 positive phenylketonuria

---

Equinox Gold Announces Positive Pre-Feasibility Study for Aurizona Expansion and 73% Increase to Mineral Reserves
Published: 2021-09-20 (Crawled : 11:00) - prnewswire.com
EQX | $5.77 1.76% 1.6M |

Non-Energy Minerals

| -19.23% | O: 0.85% H: 0.0% C: -1.27%
expansion positive

---

Farmland Partners Inc. Shares Impact from Hurricanes Ida and Nicholas (No Significant Damage) and Strong Positive Lease Renewal Trends
Published: 2021-09-20 (Crawled : 11:00) - prnewswire.com
FPI 4 | $10.865 0.51% 76K |

Finance

| -14.61% | O: -1.66% H: 1.37% C: -0.16%
positive

---

Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published: 2021-09-20 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.85 1.49% 920K |

Health Technology

| -4.07% | O: -1.35% H: 0.0% C: 0.0%
BNTX | News | $88.54 0.6% 220K |

Health Technology

| -76.28% | O: -8.02% H: 3.64% C: -0.64%
covid positive results topline children vaccine trial

---

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.56 162.07% 21M |

AGBA | $2.74 119.2% 52M |

Finance

CZOO | $9.07 81.76% 22M |

EDBL | News | $6.56 74.47% 1.8M |

OPRT | News | $3.37 49.78% 8.9M |

Finance

MTC | $2.21 41.67% 5.6M |

Technology Services

VNRX | $0.7945 32.42% 3.1M |

Health Technology

MLEC | $1.81 29.29% 2.8M |

n/a

BTCM | $3.45 27.78% 640K |

Arts, Entertainment, and Recrea...

PALI | $6.29 27.59% 22M |

Manufacturing

---

Your saved searches

---